Assessment of the cellular internalization of thermolytic phosphorothioate DNA oligonucleotide prodrugs

Harsh V Jain1, Kazuyo Takeda, Cecilia Tami

  • 1Laboratory of Chemistry, FDA-CDER, 8800 Rockville Pike, Bethesda, MD 20892, USA.

Insights

Researchers improved DNA prodrug delivery by modifying thiophosphate groups. This enhanced cellular uptake significantly, showing promise for nucleic acid-based therapeutics without observed toxicity.

Area of Science:

  • Medicinal Chemistry
  • Molecular Biology
  • Drug Delivery

Background:

  • Oligonucleotide therapeutics offer potential but face delivery challenges.
  • Thermosensitive DNA prodrugs with specific chemical modifications are being explored.
  • Cellular internalization is a critical step for prodrug efficacy.

Purpose of the Study:

  • To investigate factors influencing the cellular uptake of thermosensitive DNA prodrugs.
  • To evaluate the impact of modifying thiophosphate groups on prodrug internalization.
  • To assess the safety and intracellular trafficking of enhanced DNA prodrugs.

Main Methods:

  • Flow cytometry and confocal microscopy were used to analyze cellular uptake.
  • Synthesis and modification of DNA oligonucleotides with specific thiophosphate groups.
  • Cytotoxicity assays were performed on various cell lines (Vero, HeLa, GC-2).

Main Results:

  • Standard fma-phosphorothioate DNA sequences showed poor cellular internalization.
  • Replacing fma groups with 3-(N,N-dimethylamino)prop-1-yl thiophosphate significantly increased uptake (4-40 fold).
  • No cytotoxicity was observed in Vero cells at concentrations up to 50 μM for 72 hours.

Conclusions:

  • Incorporating 3-(N,N-dimethylamino)prop-1-yl thiophosphate groups enhances DNA prodrug internalization.
  • This modification strategy facilitates efficient cellular uptake and nuclear trafficking.
  • Positively charged DNA prodrugs show potential for therapeutic applications in nucleic acid-based drug delivery.

Related Concept Videos